The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Diabetes Mellitus and the Risk of Cancer: Results From a Large-Scale Population-Based Cohort Study in Japan
Abstract
BACKGROUND: An association between diabetes mellitus (DM) and cancer has long been speculated, but no conclusive evidence has been obtained. METHODS: We prospectively examined the association between a history of DM and subsequent risk of cancer in the Japan Public Health Center-Based Prospective Study. A total of 97 771 general Japanese persons (46 548 men and 51 223 women) aged 40 to 69 years who responded to the baseline questionnaire, from January 1990 to December 1994, were followed up for cancer incidence through December 31, 2003. At baseline, 6.7% of men and 3.1% of women had a history of DM. RESULTS: A total of 6462 cases of newly diagnosed cancer were identified. In men, a 27% increase in the risk of total cancer incidence was observed in those with a history of DM (n = 3907 [366 with DM]; hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.14-1.42). The HR was especially high for those with cancer of the liver (n = 312 [52 with DM]; HR, 2.24; 95% CI, 1.64-3.04), pancreas (n = 118 [16 with DM]; HR, 1.85; 95% CI, 1.07-3.20), and kidney (n = 99 [13 with DM]; HR, 1.92; 95% CI, 1.06-3.46). We also observed a moderately increased risk of colon cancer (n = 491 [46 with DM]; HR, 1.36; 95% CI, 1.00-1.85) and of stomach cancer with borderline significance (n = 977 [87 with DM]; HR, 1.23; 95% CI, 0.98-1.54). In women, a borderline significant increase in risk was observed for the incidence of total cancer (n = 2555 [104 with DM]; HR, 1.21; 95% CI, 0.99-1.47), while statistical significance was observed for the incidence of stomach cancer (n = 362 [20 with DM]; HR, 1.61; 95% CI, 1.02-2.54) and liver cancer (n = 120 [10 with DM]; HR, 1.94; 95% CI, 1.00-3.73) and borderline significance was observed for the incidence of ovarian cancer (n = 74 [5 with DM]; HR, 2.42; 95% CI, 0.96-6.09). CONCLUSION: Patients with DM drawn from the general Japanese population may be at increased risk of total cancer and of cancer in specific sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The underlying mechanisms of tumorigenesis in T2DM seem to be related to insulin resistance, hyperinsulinemia, elevated levels of IGF-1 [140-142], and hyperglycemia with the latter driving ATP production in cancer cells through the glycolytic pathway, a mechanism known as the Warburg effect [142].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [140]
Citations
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,294
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 989
Le Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 848
Giovannucci, E. L. (1995) · Cancer Causes & Control · doi:10.1007/bf00052777 · Cited by 808
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J. M., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Flagged first, then by citations
Cited by
Sorted by citations
Epidemiology and risk factors for kidney cancer
Chow, W.-H., Dong, L. M., & Devesa, S. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.46 · Cited by 1,395
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 884
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Marengo, A., Rosso, C., & Bugianesi, E. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-090514-013832 · Cited by 757
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.003 · Cited by 685
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 706
Metformin: An Old But Still the Best Treatment for Type 2 Diabetes
Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545
Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 548
Wang, C., Wang, X., Gong, G., Ben, Q., Qiu, W., Chen, Y., Guo-ping, L., & Wang, L. (2011) · International Journal of Cancer · doi:10.1002/ijc.26165 · Cited by 452
Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.005 · Cited by 423
Diabetes and breast cancer risk: A meta-analysis
Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., Fairley, L.-L., Boniol, M., Zheng, T., Zhang, Y., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.414 · Cited by 358
Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer?
Yuhara, H., Steinmaus, C., Cohen, S. E., Corley, D. A., Tei, Y., & Buffler, P. A. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.301 · Cited by 374
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue, F., & Michels, K. B. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.823s · Cited by 354
A review of the relationship between tooth loss, periodontal disease, and cancer
Meyer, M. S., JOSHIPURA, K. J., Giovannucci, E. L., & Michaud, D. S. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9163-4 · Cited by 351
Japanese Clinical Practice Guideline for Diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13306 · Cited by 346
Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Dandona, P., & Dhindsa, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2724 · Cited by 313
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis
Wang, P., Kang, D., Cao, W., Wang, Y., & Liu, Z. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1291 · Cited by 316
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., Tokushige, K., & Shiratori, K. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2262-x · Cited by 308
Stepanova, M., Rafiq, N., & Younossi, Z. M. (2010) · Gut · doi:10.1136/gut.2010.213553 · Cited by 301
Donadon, V., Balbi, M., Mas, M. D., Casarin, P., & Zanette, G. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02223.x · Cited by 292
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 296
Risk of cancer in a large cohort of U.S. veterans with diabetes
Atchison, E. A., Gridley, G., Carreon, J. D., Leitzmann, M. F., & McGlynn, K. A. (2010) · International Journal of Cancer · doi:10.1002/ijc.25362 · Cited by 262
Pancreatogenic Diabetes: Special Considerations for Management
Cui, Y., & Andersen, D. K. (2011) · Pancreatology · doi:10.1159/000329188 · Cited by 256
Diabetes mellitus and cancer risk: Review of the epidemiological evidence
Shikata, K., Ninomiya, T., & Kiyohara, Y. (2012) · Cancer Science · doi:10.1111/cas.12043 · Cited by 247
Jiang, Y., Ben, Q., Shen, H., Lu, W., Zhang, Y., & Zhu, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9617-y · Cited by 220
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
Bansal, D., Bhansali, A. K., Kapil, G., Undela, K., & Tiwari, P. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.40 · Cited by 208
Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.002 · Cited by 211
Chen, Y., Wu, F., Saito, E., Lin, Y., Song, M., Luu, H. N., Gupta, P. C., Sawada, N., Tamakoshi, A., Shu, X., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4229-z · Cited by 207
Self-citationDeng, L., Gui, Z., Zhao, L., Wang, J., & Shen, L. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2055-1 · Cited by 202
Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma
Sawada, N., Inoue, M., Iwasaki, M., Sasazuki, S., Shimazu, T., Yamaji, T., Takachi, R., Tanaka, Y., Mizokami, M., & Tsugane, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.018 · Cited by 200
Self-citationOhkuma, T., Peters, S. A. E., & Woodward, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4664-5 · Cited by 188
Effects of hyperglycemia on the progression of tumor diseases
Li, W., Zhang, X., Sang, H., Zhou, Y., Shang, C., Wang, Y., & Zhu, H. Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1309-6 · Cited by 188
Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies
Larsson, S. C., & Wolk, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2051-6 · Cited by 188
Anothaisintawee, T., Wiratkapun, C., Lerdsitthichai, P., Kasamesup, V., Wongwaisayawan, S., Srinakarin, J., Hirunpat, S., Woodtichartpreecha, P., Boonlikit, S., Teerawattananon, Y., et al. (2013) · Asia Pacific Journal of Public Health · doi:10.1177/1010539513488795 · Cited by 179
Should we undertake surveillance for HCC in patients with NAFLD?
Younes, R., & Bugianesi, E. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.006 · Cited by 165
Insulin resistance and cancer: Epidemiological evidence
Tsugane, S., & Inoue, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01521.x · Cited by 175
Self-citationNoto, H., Tsujimoto, T., Sasazuki, T., & Noda, M. (2011) · Endocrine Practice · doi:10.4158/ep10357.ra · Cited by 169
Diabetes increases the risk of breast cancer: a meta-analysis
Hardefeldt, P. J., Edirimanne, S., & Eslick, G. D. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0242 · Cited by 164
Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature.
Liao, S., Li, J., Wei, W., Wang, L., Zhang, Y., Li, J., Wang, C., & Sun, S. (2011) · PubMed · Cited by 164
The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
Hsieh, M.-C., Lee, T.-C., Cheng, S.-M., Tu, S., Yen, M., & Tseng, C. (2012) · Experimental Diabetes Research · doi:10.1155/2012/413782 · Cited by 166
Tan, B., Yao, W., Ge, J., Peng, X., Du, X., Zhang, R., Yao, B., Xie, K., Li, L., Dong, H., et al. (2011) · Cancer · doi:10.1002/cncr.26151 · Cited by 161
Obesity and Diabetes Epidemics:
Hjartåker, A., Langseth, H., & Weiderpass, E. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78818-0_6 · Cited by 157
Rizos, C. V., & Elisaf, M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.02.038 · Cited by 156
Epidemiological aspects of neoplasms in diabetes
Nicolucci, A. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0187-3 · Cited by 154
Metformin and cancer: An existing drug for cancer prevention and therapy (Review)
Zi, F., Zi, H., Li, Y., He, J., Shi, Q., & Cai, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7412 · Cited by 156
Lee, J., Jeon, I., Lee, J. M., Yoon, J.-M., & Park, S. M. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.025 · Cited by 147
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
Donadon, V., Balbi, M., Ghersetti, M., Grazioli, S., Perciaccante, A., Valentina, G. D., Gardenal, R., Mas, M. D., Casarin, P., Zanette, G., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2506 · Cited by 145
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
Johnson, J. A., & Bowker, S. L. (2010) · Diabetologia · doi:10.1007/s00125-010-1933-3 · Cited by 145
Campbell, P. T., Deka, A., Jacobs, E. J., Newton, C. C., Hildebrand, J. S., McCullough, M. L., Limburg, P. J., & Gapstur, S. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.072 · Cited by 143
Diabetes and Pancreatic Cancer: Chicken or Egg?
Magruder, J. T., Elahi, D., & Andersen, D. K. (2011) · Pancreas · doi:10.1097/mpa.0b013e318209e05d · Cited by 140
Diabetes and cancer: A comprehensive review
Abudawood, M. (2019) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_242_19 · Cited by 146
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma
Dhamija, E., Paul, S. B., & Kedia, S. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1456_17 · Cited by 139
Lai, S., Liao, K., Chen, P., Tsai, P., Hsieh, D. P. H., & Chen, C. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.10.002 · Cited by 138
Sun, L., Fang, S., Iqbal, S., & Bilal, A. R. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17439-w · Cited by 147
Yang, W.-S., Va, P., Bray, F., Gao, S., Gao, J., Li, H. L., & Xiang, Y.-B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027326 · Cited by 136
Inhibition of GSK‐3β activity attenuates proliferation of human colon cancer cells in rodents
Shakoori, A., Mai, W., Miyashita, K., Yasumoto, K., Takahashi, Y., Ooi, A., Kawakami, K., & Minamoto, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00545.x · Cited by 136
Transformed Drosophila Cells Evade Diet-Mediated Insulin Resistance through Wingless Signaling
Hirabayashi, S., Baranski, T., & Cagan, R. L. (2013) · Cell · doi:10.1016/j.cell.2013.06.030 · Cited by 138
Colorectal cancer in the world: incidence, mortality and risk factors
Gandomani, H. S., yousefi, S. M., Aghajani, M., Mohammadian-Hafshejani, A., Tarazoj, A. A., Pouyesh, V., & Salehiniya, H. (2017) · Biomedical Research and Therapy · doi:10.15419/bmrat.v4i10.372 · Cited by 133
Steele, C. B., Cardinez, C. J., Richardson, L. C., Tom-Orme, L., & Shaw, K. M. (2008) · Cancer · doi:10.1002/cncr.23727 · Cited by 131
Diabetes and risk of incident cancer: a large population-based cohort study in Israel
Chodick, G., Heymann, A. D., Rosenmann, L., Green, M. S., Flash, S., Porath, A., Kokia, E. S., & Shalev, V. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9515-8 · Cited by 128
Mizoue, T., Inoue, M., Wakai, K., Nagata, C., Shimazu, T., Tsuji, I., Otani, T., Tanaka, K., Matsuo, K., Tamakoshi, A., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn073 · Cited by 128
Self-citationSubstantially increased risk of cancer in patients with diabetes mellitus
Noto, H., Osame, K., Sasazuki, T., & Noda, M. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.06.004 · Cited by 126
Diabetes and cancer I: risk, survival, and implications for screening
Onitilo, A. A., Engel, J. M., Glurich, I., Stankowski, R. V., Williams, G. M., & Doi, S. A. R. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9972-3 · Cited by 127
Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?
Hashimoto, E., & Tokushige, K. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00872.x · Cited by 120
Diabetes and Thyroid Cancer Risk in the National Institutes of Health-AARP Diet and Health Study
Aschebrook‐Kilfoy, B., Sabra, M. M., Brenner, A. V., Moore, S. C., Ron, E., Schatzkin, A. G., Hollenbeck, A. R., & Ward, M. H. (2011) · Thyroid · doi:10.1089/thy.2010.0396 · Cited by 121
KATO, M., NODA, M., INOUE, M., KADOWAKI, T., & TSUGANE, S. (2009) · Endocrine Journal · doi:10.1507/endocrj.k09e-003 · Cited by 120
Self-citationTaninaga, J., Nishiyama, Y., Fujibayashi, K., Gunji, T., Sasabe, N., Iijima, K., & Naito, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-48769-y · Cited by 120
Diabetes and Cancer: Is Diabetes Causally Related to Cancer?
Suh, S., & Kim, K. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.3.193 · Cited by 122
Yin, D., He, H., Yu, K., Xie, J., Lei, M., Ma, R., Li, H., Wang, Y., & Liu, Z. (2018) · International Journal of Surgery · doi:10.1016/j.ijsu.2018.07.013 · Cited by 110
Diabetes mellitus and cancer risk: Pooled analysis of eight cohort studies in Japan
Sasazuki, S., Charvat, H., Hara, A., Wakai, K., Nagata, C., Nakamura, K., Tsuji, I., Sugawara, Y., Tamakoshi, A., Matsuo, K., et al. (2013) · Cancer Science · doi:10.1111/cas.12241 · Cited by 109
Self-citationHepatitis C virus infection and type 1 and type 2 diabetes mellitus
Antonelli, A. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.586 · Cited by 113
Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts
Ma, Y., Yang, W., Song, M., Smith‐Warner, S. A., Yang, J., Li, Y., Ma, W., Hu, Y., Ogino, S., Hu, F. B., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0314-4 · Cited by 111
Risk Factors for Hepatocellular Carcinoma in a Japanese Population: A Nested Case-Control Study
Ohishi, W., Fujiwara, S., COLOGNE, J. B., Suzuki, G., Akahoshi, M., Nishi, N., Takahashi, I., & Chayama, K. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2806 · Cited by 106
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
Okanoue, T., Umemura, A., Yasui, K., & Itoh, Y. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06547.x · Cited by 102
Wang, C.-S., Yao, W., Chang, T., Wang, S., & Chou, P. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1131 · Cited by 104
Diabetes Mellitus and Ovarian Cancer Risk
Lee, J., Jeon, I., Kim, J., Song, Y. S., Yoon, J.-M., & Park, S. M. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31828189b2 · Cited by 103
Nyane, N. A., Tlaila, T. B., Malefane, T. G., Ndwandwe, D. E., & Owira, P. M. O. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.042 · Cited by 101
Diabetes Mellitus and Risk of Thyroid Cancer: A Meta-Analysis
Yeo, Y., Ma, S.-H., Hwang, Y., Horn‐Ross, P. L., Hsing, A. W., Lee, K.-E., Park, Y. J., Park, D.-J., Yoo, K., & Park, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098135 · Cited by 101
PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
Aljada, A., O’Connor, L., Fu, Y.-Y., & Mousa, S. A. (2008) · Angiogenesis · doi:10.1007/s10456-008-9118-0 · Cited by 99
Diabetes mellitus and incidence and mortality of kidney cancer: A meta-analysis
Bao, C., Yang, X., Xu, W., Luo, H., Xu, Z., Su, C., & Qi, X. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.01.004 · Cited by 98
Diabetes and cancer risk: A Mendelian randomization study
Goto, A., Yamaji, T., Sawada, N., Momozawa, Y., Kamatani, Y., Kubo, M., Shimazu, T., Inoue, M., Noda, M., Tsugane, S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32310 · Cited by 100
Self-citationSerum interleukin‐6 associated with hepatocellular carcinoma risk: A nested case–control study
Ohishi, W., COLOGNE, J. B., Fujiwara, S., Suzuki, G., Hayashi, T., Niwa, Y., Akahoshi, M., Ueda, K., Tsuge, M., & Chayama, K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28337 · Cited by 97
Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
Lam, E. K. K., Batty, G. D., Huxley, R., Martiniuk, A. L. C., Barzi, F., Lam, T., Lawes, C. M. M., Giles, G. G., Welborn, T. A., Ueshima, H., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq405 · Cited by 93
Chen, H.-F., Chen, P., & Li, C. (2010) · Hepatology · doi:10.1002/hep.23641 · Cited by 93
Zhu, Z., Wang, X., Shen, Z., Lu, Y., Zhong, S., & Chen, X. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-310 · Cited by 93
Rising trends in pancreatic cancer incidence and mortality in 2000–2014
Wu, W., He, X., Yang, L., Wang, Q., Bian, X., Ye, J., Li, Y., & Li, L. (2018) · Clinical Epidemiology · doi:10.2147/clep.s160018 · Cited by 91
Fang, H., Yao, B., Yan, Y., Xu, H., Liu, Y., Tang, H., Zhou, J., Cao, L., Wang, W., Zhang, J., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0131 · Cited by 92
Koh, W.-P., Wang, R., Jin, A., Yu, M. C., & Yuan, J.-M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.25 · Cited by 92
Type 2 diabetes mellitus and colorectal cancer: Meta-analysis on sex-specific differences
Krämer, H. U., Schöttker, B., Raum, E., & Brenner, H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.010 · Cited by 96
Mei, Z., Zhang, Z.-J., Liu, C., Liu, Y., Cui, A., Liang, Z., Wang, G., & Cui, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091818 · Cited by 89
Pre-existing diabetes mellitus increases the risk of gastric cancer: A meta-analysis
Yoon, J. M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i6.936 · Cited by 89
Latest insights into the risk of cancer in diabetes
Noto, H., Goto, A., Tsujimoto, T., Osame, K., & Noda, M. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12068 · Cited by 90
Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry
Yang, X., So, W. Y., Ronald, C. W., Yu, L. W., Ko, G. T. C., Kong, A. P. S., Ng, V., Luk, A. O. Y., Ozaki, R., Tong, P. C. Y., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.08.022 · Cited by 88
Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis
Ren, H., Yu, T., Liu, C., & Li, Y. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9754-3 · Cited by 88
Díaz, V. A., Mainous, A. G., Carek, P. J., Wessell, A. M., & Everett, C. J. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.05.080231 · Cited by 87
Lee, K., Inoue, M., Otani, T., Iwasaki, M., Sasazuki, S., Tsugane, S., & for the JPHC Study Group (2007) · International Journal of Cancer · doi:10.1002/ijc.22778 · Cited by 86
Self-citationOda, K., Uto, H., Mawatari, S., & Ido, A. (2015) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-014-0548-5 · Cited by 85
Zhou, Y.-Y., Zhu, G.-Q., Liu, T., Zheng, J.-N., Cheng, Z., Zou, T.-T., Braddock, M., Fu, S.-W., & Zheng, M.-H. (2016) · Scientific Reports · doi:10.1038/srep33743 · Cited by 69
Cardiovascular Disease and Cancer: Is There Increasing Overlap?
Vincent, L. L., Leedy, D. J., Masri, S. C., & Cheng, R. K.-H. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0796-0 · Cited by 88
Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis
Schmid, D., Behrens, G., Jochem, C., Keimling, M., & Leitzmann, M. F. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9865-0 · Cited by 83
Metadata
- Authors
- Inoue, M.
- Affiliations
- National Cancer Centre Japan (JP)
- Corresponding author
- Inoue, Manami
- ORCID
- Inoue, Manami
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-09-25
- Volume
- 166
- Issue
- 17
- Pages
- 1871
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2096623507
- Cited by
- 561
- References
- 59
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 20 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 28 · 2019: 29 · 2018: 22 · 2017: 35 · 2016: 22 · 2015: 31 · 2014: 41 · 2013: 51 · 2012: 55
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- diabetes mellitus, cancer risk, cancer incidence, liver cancer, pancreatic cancer, kidney cancer, colon cancer, gastric cancer, sex differences, Japan Public Health Center-based Prospective Study, Japanese adults, prospective cohort, hazard ratio, cancer mortality, cancer prevention, lifestyle modification, cancer survivorship, cancer survivorship support services
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Digestive System Neoplasms, Female, Humans, Japan, Male, Middle Aged, Neoplasms, Prospective Studies, Risk Factors, Incidence, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review